.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Modern pharmacology faces high costs and long development cycles. Consequently, researchers are turning to a drug repositioning web server like DRHIN to find new uses for approved medications. This integrated platform utilizes deep learning to analyze complex biological networks. Specifically, it combines transcriptomics, proteomics, and microbiome data into heterogeneous information networks. By doing so, it clarifies the molecular mechanisms that drive drug effectiveness across different diseases.
DRHIN stands out because it incorporates 19 state-of-the-art graph representation algorithms. These tools allow scientists to compare and evaluate network data with high precision. Furthermore, the platform offers a code-free portal. This accessibility enables clinicians to perform predictive tasks without needing deep programming knowledge. In addition, high-performance computing ensures that the system processes million-scale networks quickly. Clinicians can use these insights to repurpose existing drugs for new indications or identify potential therapies for specific diseases.
Repurposing existing drugs reduces the safety risks associated with new chemical entities. Moreover, it significantly lowers the financial burden of drug development. Therefore, tools like DRHIN empower the global medical community to deliver safer treatments faster. Similarly, the platform makes analyses reproducible and accessible for researchers worldwide. In conclusion, DRHIN provides a robust framework for identifying potential therapies in real-world scenarios.
DRHIN acts as a specialized drug repositioning web server that analyzes biological data to find new therapeutic indications for existing, approved drugs.
The platform integrates transcriptomics, proteomics, and microbiome data across eight biological entities and 19 association types to build comprehensive networks.
No, DRHIN provides a code-free portal, making complex deep learning analyses accessible to medical professionals and researchers without programming expertise.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a substitute for professional healthcare consultation. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
DRHIN uses deep learning and heterogeneous information networks to repurpose existing drugs, offering a cost-effective path for new disease treatments....
3 months ago
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
